- gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells. Walker, E.B., Haley, D., Miller, W., Floyd, K., Wisner, K.P., Sanjuan, N., Maecker, H., Romero, P., Hu, H.M., Alvord, W.G., Smith, J.W., Fox, B.A., Urba, W.J. Clin. Cancer Res. (2004)